Require Prescription
Description: Aimovig (erenumab) 70 mg Solution for Injection in Prefilled Pen is a medication used for the preventive treatment of migraine in adults. It belongs to a class of medications known as calcitonin gene-related peptide (CGRP) inhibitors, which specifically target the CGRP receptor involved in migraine pathophysiology. The prefilled pen offers a convenient and user-friendly method for self-administration.
Ingredients:
- Active ingredient: Erenumab-aooe (erenumab) 70 mg.
- Other ingredients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, sucrose, and water for injection.
Usage Instructions:
- Administer Aimovig using the prefilled pen subcutaneously (under the skin) as directed by your healthcare provider.
- Dosage: The recommended dose is 70 mg once monthly.
- Frequency: Administered once monthly.
- Special considerations: Follow the instructions provided in the product leaflet for proper use of the prefilled pen. Inject into the thigh or abdomen.
Benefits: • Reduces the frequency and severity of migraine attacks. • Helps improve quality of life by providing effective migraine prevention. • Convenient prefilled pen for easy and accurate self-administration. • Targeted therapy with minimal systemic side effects.
Precautions: • Not suitable for individuals with known hypersensitivity to erenumab or any component of the formulation. • Possible side effects include injection site reactions, constipation, and hypersensitivity reactions. • Monitor for signs of hypersensitivity and adverse reactions during treatment. • Consult a healthcare provider before use if pregnant, breastfeeding, or planning pregnancy. • Keep out of reach of children.
Storage Instructions: • Store in the refrigerator at 2-8°C (36-46°F). • Keep the prefilled pen in its original carton to protect from light. • Do not freeze. If the prefilled pen has been frozen, do not use it. • Do not use after the expiration date.
Manufacturer: Amgen Europe B.V.
